Hume Richard T. - 02 Feb 2026 Form 4 Insider Report for TD SYNNEX CORP (SNX)

Role
Director
Signature
/s/ Cheryl Grant, attorney-in-fact
Issuer symbol
SNX
Transactions as of
02 Feb 2026
Net transactions value
-$1,782,085
Form type
4
Filing time
04 Feb 2026, 17:52:07 UTC
Previous filing
02 Feb 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HUME RICHARD T Director 5350 TECH DATA DRIVE, CLEARWATER /s/ Cheryl Grant, attorney-in-fact 04 Feb 2026 0001669810

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNX Common Stock Options Exercise $1,970,932 +18,365 +39% $107.32 65,880 02 Feb 2026 Direct F1
transaction SNX Common Stock Sale $34,055 -216 -0.33% $157.66 65,664 02 Feb 2026 Direct F1, F2
transaction SNX Common Stock Sale $37,425 -236 -0.36% $158.58 65,428 02 Feb 2026 Direct F1, F3
transaction SNX Common Stock Sale $84,130 -527 -0.81% $159.64 64,901 02 Feb 2026 Direct F1, F4
transaction SNX Common Stock Sale $2,744,281 -17,093 -26% $160.55 47,808 02 Feb 2026 Direct F1, F5
transaction SNX Common Stock Sale $853,126 -5,293 -11% $161.18 42,515 02 Feb 2026 Direct F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNX Employee Stock Option (Right to Buy) Options Exercise $0 -18,365 -100% $0.000000 0 02 Feb 2026 Common Stock 18,365 $107.32 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The stock option exercises and sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2025.
F2 Represents the weighted average sales price for a number of transactions effected at prices ranging from $157.115 to $157.995. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
F3 Represents the weighted average sales price for a number of transactions effected at prices ranging from $158.365 to $158.88. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
F4 Represents the weighted average sales price for a number of transactions effected at prices ranging from $159.07 to $159.955. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
F5 Represents the weighted average sales price for a number of transactions effected at prices ranging from $160.00 to $160.995. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
F6 Represents the weighted average sales price for a number of transactions effected at prices ranging from $161.00 to $161.51. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
F7 This stock option is fully vested.